| |
|
Group's Investments
|
|
|
|
| |
|
|
Aeterna Zentaris
Development of medication to fight cancer and other diseases |
|
17%
|
|
SGF
Solidarity Fund QFL, Other |
Axcan Pharma Inc.
Development and production of prescription products in the field of gastroenterology |
|
N/A
|
|
SGF
TPG Capital
Other |
|
Atrium Innovations
Production and distribution of dietary supplements and health products
|
|
6%
|
|
SGF
Aeterna Laboratories inc.
Solidarity Fund QFL
Private Investor
Fonds d’investissement bioalimentaire |
Biotechnologies Océanova
Production of active ingredients obtained from the St-Lawrence marine biomass |
|
31%
|
|
SGF
Atrium,
Bio-Innovation, Solidarity Fund QFL |
GeneChem Thérapeutiques
Venture capital fund specialized in research projects and companies involved in genomics |
|
7%
|
|
SGF
Fonds Bombardier, Shire Pharmaceutical, Solidarity Fund QFL |
MédiaMed Technologies
Innovative technological solutions and consulting services used by hospitals and health care and social services centres. |
|
46%
|
|
SGF |
|
Médicago
Manufacturing of recombinant proteins for pharmaceutical use
|
|
8%
|
|
SGF
Other |
Génopole Premier jour
Investment Fund |
|
6%
|
|
SGF
CDC Entreprises, Groupe Industriel Marcel Dassault, FSTQ |
|
Warnex
Specialized analytical, bioanalytical and medical laboratory services
|
|
25%
|
|
SGF
Public |
|
|
|
|